C. Lazor-Blanchet a, P. Zygoura b, U. Dafni b, c, F. Lamoth d, e, Z. Tsourti b, M.A. Lobritz f, J. Regina d, B. Grandbastien g, C. Fenwick h, G. Pantaleo h, T. Calandra d, S. Meylan d, ⁎
a Occupational health unit, Service of Hospital Preventive Medicine, Lausanne University Hospital, Lausanne, Switzerland
b Frontier Science Foundation-Hellas, Athens, Greece
c National and Kapodistrian University of Athens, Athens, Greece
d Infectious Diseases Service, Department of Medicine, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland
e Institute of Microbiology, Lausanne University Hospital and University, Lausanne, Switzerland
f Roche Pharma Research and Early Development, Roche Innovation Center Basel, Basel, Switzerland
g Service of Hospital Preventive Medicine, Lausanne University Hospital, University of Lausanne, Lausanne, Switzerland
h Immunology Service, Department of Medicine, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland